• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; IMPLANTED DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; IMPLANTED DEVICE Back to Search Results
Model Number G158
Device Problem Difficult to Insert (1316)
Patient Problems No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device has been returned for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that during a scheduled left ventricular (lv) lead replacement procedure, the terminal end of the newly implanted lv lead did not fit in the device header of this existing cardiac resynchronization therapy defibrillator (crt-d) device.As a result, the device was explanted and replaced during the same procedure.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Patient code 3191 captures the reportable event of surgery.The device has been returned for analysis.This report will be updated upon completion of analysis.The associated investigation noted evidence indicating difficulty may have been encountered fully inserting a left ventricular (lv) is-1 lead into the header of this device with an is-4 lv connector port.Please refer to the description for more information regarding the specific circumstances of this event.The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header noted dried blood in the lv set screw terminal block area and in the lv lead barrel.There is a hole in the lv seal plug and the right atrial (ra) and right ventricular (rv) seal plugs are intact.The set screws operate normally.As part of additional testing, a lv lead with an is-4 terminal connector was inserted into the device lv port.The lead was easily and completely inserted.The set screw was tightened and held the lead in place.The device has normal battery voltage and the batter status is beginning of life (bol).A review of device memory noted no fault cades.A series of electrical tests were also performed, and normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Event Description
It was reported that during a scheduled left ventricular (lv) lead replacement procedure, the terminal end of the newly implanted lv lead did not fit in the device header of this existing cardiac resynchronization therapy defibrillator (crt-d) device.As a result, the device was explanted and replaced during the same procedure.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN X4 CRT-D
Type of Device
IMPLANTED DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10620781
MDR Text Key209609869
Report Number2124215-2020-18021
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534904
UDI-Public00802526534904
Combination Product (y/n)N
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/23/2021
Device Model NumberG158
Device Catalogue NumberG158
Device Lot Number221152
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/17/2020
Date Manufacturer Received03/29/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age56 YR
-
-